FDA Peptide Reclassification 2026 Amanecia Health RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions